This inventor holds 2 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Novartis Ag. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Boston, MA (US) (2018)
- Needham, MA (US) (2021)
Company Filing History:


Years Active: 2018-2021
Title: Elaine M Pinheiro: Innovator in Cancer Treatment
Introduction
Elaine M Pinheiro is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 2 patents, her work focuses on developing effective therapies for combating cancer.
Latest Patents
Elaine's latest patents include groundbreaking methods for treating cancer. One of her notable inventions is titled "Compositions and methods for treating cancer with a combination of programmed death receptor (PD-1) antibodies and a CXCR2 antagonist." This invention outlines methods for treating cell proliferation disorders, such as cancer, by administering specific compounds and anti-human PD-1 antibodies to patients in need. Additionally, she has developed a patent for "Combination therapies for cancer," which involves a novel combination of a B-Raf inhibitor, a MEK inhibitor, and a PD-1 antagonist. These therapeutic combinations aim to enhance treatment efficacy for various cancer conditions.
Career Highlights
Elaine has worked with leading pharmaceutical companies, including Merck Sharp & Dohme Corp. and Novartis AG. Her experience in these organizations has allowed her to contribute to the advancement of cancer therapies and collaborate with other experts in the field.
Collaborations
Some of her notable coworkers include Axel Hoos and Keith W Orford. Their collaboration has further enriched the research and development of innovative cancer treatments.
Conclusion
Elaine M Pinheiro's contributions to cancer treatment through her patents and collaborations highlight her dedication to improving patient outcomes. Her innovative approaches continue to pave the way for advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile